A detailed history of Walleye Trading LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Walleye Trading LLC holds 9,997 shares of REGN stock, worth $7.02 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,997
Previous 800 1149.63%
Holding current value
$7.02 Million
Previous $840,000 1151.07%
% of portfolio
0.02%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1024.09 - $1201.76 $1.97 Million - $2.31 Million
-1,921 Reduced 16.12%
9,997 $10.5 Million
Q2 2024

Aug 14, 2024

BUY
$883.2 - $1071.19 $6.37 Million - $7.73 Million
7,215 Added 153.41%
11,918 $12.5 Million
Q1 2024

May 15, 2024

BUY
$902.69 - $993.35 $2.78 Million - $3.06 Million
3,085 Added 190.67%
4,703 $4.53 Million
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $1.25 Million - $1.43 Million
1,618 New
1,618 $1.42 Million
Q2 2023

Aug 14, 2023

BUY
$700.03 - $830.35 $3.33 Million - $3.96 Million
4,764 New
4,764 $3.42 Million
Q2 2022

Aug 08, 2022

BUY
$548.35 - $738.84 $5.14 Million - $6.93 Million
9,381 Added 183.8%
14,485 $8.56 Million
Q1 2022

May 16, 2022

BUY
$595.12 - $698.43 $2.22 Million - $2.61 Million
3,732 Added 272.01%
5,104 $3.57 Million
Q3 2021

Nov 15, 2021

SELL
$574.03 - $680.96 $2.43 Million - $2.88 Million
-4,236 Reduced 75.53%
1,372 $830,000
Q2 2021

Aug 16, 2021

BUY
$472.8 - $558.54 $1.05 Million - $1.24 Million
2,219 Added 65.48%
5,608 $3.13 Million
Q1 2021

May 17, 2021

SELL
$446.73 - $548.2 $3.84 Million - $4.71 Million
-8,589 Reduced 71.71%
3,389 $1.6 Million
Q4 2020

Feb 16, 2021

BUY
$478.3 - $607.98 $5.02 Million - $6.38 Million
10,495 Added 707.69%
11,978 $5.79 Million
Q3 2020

Nov 16, 2020

BUY
$544.75 - $658.21 $223,347 - $269,866
410 Added 38.21%
1,483 $830,000
Q1 2020

May 15, 2020

SELL
$336.18 - $494.43 $1.04 Million - $1.53 Million
-3,104 Reduced 74.31%
1,073 $524,000
Q4 2019

Feb 14, 2020

BUY
$274.13 - $376.51 $478,082 - $656,633
1,744 Added 71.68%
4,177 $1.57 Million
Q4 2018

Feb 14, 2019

SELL
$335.82 - $403.04 $905,706 - $1.09 Million
-2,697 Reduced 52.57%
2,433 $909,000
Q3 2018

Nov 14, 2018

SELL
$351.14 - $408.51 $9,129 - $10,621
-26 Reduced 0.5%
5,130 $2.07 Million
Q2 2018

Aug 14, 2018

SELL
$284.6 - $344.99 $539,317 - $653,756
-1,895 Reduced 26.88%
5,156 $1.78 Million
Q1 2018

May 15, 2018

BUY
$315.82 - $393.78 $1.08 Million - $1.34 Million
3,406 Added 93.44%
7,051 $2.43 Million
Q4 2017

Feb 14, 2018

BUY
$358.63 - $469.95 $289,773 - $379,719
808 Added 28.48%
3,645 $1.37 Million
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $1.22 Million - $1.43 Million
2,837
2,837 $1.27 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.